Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

New drug TB006 shows promise in early Parkinson's trial

NCT ID NCT06773962

First seen Oct 31, 2025 · Last updated May 13, 2026 · Updated 27 times

Summary

This study tests a new drug called TB006 in 62 people with early-stage Parkinson's disease. The goal is to see if it improves movement and is safe. Participants receive either TB006 or a placebo, and neither they nor the doctors know who gets which.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for PARKINSON'S DISEASE (PD) are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Locations

  • CenExel Rocky Mountain Clinical Research

    Englewood, Colorado, 80113, United States

  • Central Texas Neurology Consultants

    Round Rock, Texas, 78681, United States

  • Consultants in Neurology, Ltd

    Northbrook, Illinois, 60062, United States

  • Josephson Wallack Munshower Neurology - Southeast

    Indianapolis, Indiana, 46256, United States

  • NYU Langone Health

    Patchogue, New York, 11772, United States

  • Oregon Health & Science University

    Portland, Oregon, 97239, United States

  • Parkinson's Disease and Movement Disorders Center of Boca Raton

    Boca Raton, Florida, 33486, United States

  • Parkinson's Research Centers of America - Long Island

    Commack, New York, 11725, United States

  • Parkinson's Research Centers of America - Orange County

    Aliso Viejo, California, 92656, United States

  • Parkinson's Research Centers of America - Palo Alto

    Palo Alto, California, 94301, United States

  • Quest Research Institute

    Farmington Hills, Michigan, 48334, United States

  • University of Kansas Medical Center

    Kansas City, Kansas, 66160, United States

  • University of Miami

    Miami, Florida, 33136, United States

  • University of South Florida Parkinson's and Movement Disorders Center

    Tampa, Florida, 33613, United States

Conditions

Explore the condition pages connected to this study.